Pharma & Biotech

The biotechnology sector is witnessing a significant corporate development as pharmaceutical titan Eli Lilly moves to acquire Adverum Biotechnologies. This...

Investors in Alx Oncology Holdings are bracing for a week of significant announcements, with two major events scheduled for early...

All eyes are on Sight Sciences as the company prepares to release its third-quarter 2025 financial results after market close...

The medical technology company's shares are showing tentative signs of stabilization following a recent downturn, but investors face a pivotal...

All eyes are on Cerus Corporation as the biotechnology firm prepares to release its third-quarter 2025 financial results this Thursday....

Aclaris Therapeutics enters a pivotal week as the market braces for the company's third-quarter 2025 financial results, scheduled for release...

A pivotal moment approaches for Germany's biotechnology landscape as shareholders of CureVac prepare to vote on November 25 regarding a...

The upcoming quarterly report from biotechnology firm Iovance represents a pivotal moment for the company's stock trajectory. On Thursday, November...

Viking Therapeutics is experiencing significant positive momentum this October, driven by substantial progress in its obesity treatment candidate VK2735. The...

After an extended period of decline, BioNTech's stock is finally demonstrating positive momentum. The vaccine pioneer recorded gains exceeding 6...